target="_blank" rel="nofollow" href="#ulink_93526a8e-416f-597e-a2ef-ee44121584c1">13Lee SY, Gallagher D: Assessment methods in human body composition. Curr Opin Clin Nutr Metab Care 2008;11:566–572.
14Geer EB, Shen W: Gender differences in insulin resistance, body composition, and energy balance. Gend Med 2009;6(suppl 1):60–75.
15Blouin K, Veilleux A, Luu-The V, Tchernof A: Androgen metabolism in adipose tissue: recent advances. Mol Cell Endocrinol 2009;301:97–103.
16Santosa S, Jensen MD: Sex and sex steroids: impact on the kinetics of fatty acids underlying body shape. Horm Mol Biol Clin Investig 2014;20:15–23.
17Pasquali R, Gambineri A: A comprehensive approach in diagnosing the polycystic ovary syndrome. Womens Health 2015;11:501–512.
18Lovejoy JC, Bray GA, Bourgeois MO, Macchiavelli R, Rood JC, Greeson C, et al: Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women – a clinical research center study. J Clin Endocrinol Metab 1996;81:2198–2203.
19Allan CA, McLachlan RI: Androgens and obesity. Curr Opin Endocrinol Diabetes Obes 2010;17:224–232.
20Giagulli VA, Kaufman JM, Vermeulen A: Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab 1994;79:997–1000.
21Gravholt CH, Jensen AS, Høst C, Bojesen A: Body composition, metabolic syndrome and type 2 diabetes in Klinefelter syndrome. Acta Paediatr 2011;100:871–877.
22Cheung AS, Hoermann R, Dupuis P, Joon DL, Zajac JD, Grossmann M: Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancer. Eur J Endocrinol 2016;175:229–237.
23Storer TW, Miciek R, Travison TG: Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy. Asian J Androl 2012;14:204–221.
24Collins L, Basaria S: Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications. Asian J Androl 2012;14:222–225.
25Santosa S, Khosla S, McCready LK, Jensen MD: Effects of estrogen and testosterone on resting energy expenditure in older men. Obesity (Silver Spring) 2010;18:2392–2394.
26Chao J, Rubinow KB, Kratz M, Amory JK, Matsumoto AM, Page ST: Short-term estrogen withdrawal increases adiposity in healthy men. J Clin Endocrinol Metab 2016;101:3724–3731.
27Vandewalle S, Taes Y, Fiers T, Toye K, Van Caenegem E, Roggen I, et al: Associations of sex steroids with bone maturation, bone mineral density, bone geometry, and body composition: a cross-sectional study in healthy male adolescents. J Clin Endocrinol Metab 2014;99:E1272–E1282.
28Vandewalle S, Taes Y, Fiers T, Van Helvoirt M, Debode P, Herregods N, et al: Sex steroids in relation to sexual and skeletal maturation in obese male adolescents. J Clin Endocrinol Metab 2014;99:2977–2985.
29Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y: Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology 2000;141:649–656.
30Blouin K, Boivin A, Tchernof A: Androgens and body fat distribution. J Steroid Biochem Mol Biol 2008;108:272–280.
31Blouin K, Nadeau M, Perreault M, Veilleux A, Drolet R, Marceau P, et al: Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women. Clin Endocrinol (Oxf) 2010;72:176–188.
32Xu X, De Pergola G, Björntorp P: The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology 1990;126:1229–1234.
33Dubois V, Laurent MR, Jardi F, Antonio L, Lemaire K, Goyvaerts L, et al: Androgen deficiency exacerbates high-fat diet-induced metabolic alterations in male mice. Endocrinology 2016;157:648–665.
34O’Connell MD, Wu FC: Androgen effects on skeletal muscle: implications for the development and management of frailty. Asian J Androl 2014;16:203–212.
35Chusyd DE, Wang D, Huffman DM, Nagy TR: Relationships between rodent white adipose fat pads and human white adipose fat depots. Front Nutr 2016;3:10.
36Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y: Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 1998;274(6 Pt 1):C1645–C1652.
37Lacasa D, Garcia E, Henriot D, Agli B, Giudicelli Y: Site-related specificities of the control by androgenic status of adipogenesis and mitogen-activated protein kinase cascade/c-fos signaling pathways in rat preadipocytes. Endocrinology 1997;138:3181–3186.
38James RG, Krakower GR, Kissebah AH: Influence of androgenicity on adipocytes and precursor cells in female rats. Obes Res 1996;4:463–470.
39Elbers JM, de Jong S, Teerlink T, Asscheman H, Seidell JC, Gooren LJ: Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals. Metabolism 1999;48:1371–1377.
40Rodriguez-Cuenca S, Monjo M, Proenza AM, Roca P: Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu. Am J Physiol Endocrinol Metab 2005;288:E200–E207.
41Veilleux A, Côté JA, Blouin K, Nadeau M, Pelletier M, Marceau P, et al: Glucocorticoid-induced androgen inactivation by aldo-keto reductase 1C2 promotes adipogenesis in human preadipocytes. Am J Physiol Endocrinol Metab 2012;302:E941–E949.
42Beilin J, Ball EM, Favaloro JM, Zajac JD: Effect of the androgen
